The constraint of global pharmaceutical supply chains has been laid bare by a series of adverse events—from the COVID-19 pandemic to war, political conflicts, and climate-induced natural disasters. These critical events have exposed the severe vulnerabilities, including overdepen...
Open access
Research Article10.9734/jpri/2025/v37i77723
Medicine serialization seems to be a key to both counterfeiting and the complex supply chain of the pharmaceutical industry, including recalls and returns. Though there are countries that use serialization as a legal necessity, it is still a developing topic within the industry....
Open access
Research Article10.9734/jalsi/2023/v26i5619
Drug counterfeiting has been a major problem for the government and regulatory agencies since the beginning of the 20th century. Most of the drug counterfeiting reported is in countries where a high demand for drugs combines with poor surveillance, quality control, regulation, an...
Open access
Research Article10.9734/jamps/2023/v25i7628
In recent years, pharmaceutical drug traceability systems have been developed as critical tools for improving the digital supply chain's transparency and visibility. Blockchain-based drug traceability proposes a promising solution to create a distributed shared data platform for...
Open access
Research Article10.9734/ajrcos/2023/v16i3353
Pharmaceutical serialization is a regulatory compliance that assures a unique identifier assigned to every unit of prescribed medicine. This unique identifier is used for product tracking and authentication in the supply chain. Initially, in 2018, the Drug Supply Chain Security A...
Open access
Research Article10.9734/cjast/2023/v42i214153